AMALGAMATED BANK - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 241 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$185
+0.5%
26,1460.0%0.00%
+100.0%
Q2 2023$184
-8.9%
26,146
+8.0%
0.00%
-50.0%
Q1 2023$202
-36.9%
24,220
-13.2%
0.00%
-33.3%
Q4 2022$320
-99.9%
27,9010.0%0.00%0.0%
Q3 2022$352,000
+20.5%
27,901
+1.2%
0.00%0.0%
Q2 2022$292,000
-22.1%
27,573
+19.4%
0.00%0.0%
Q1 2022$375,000
-43.7%
23,092
-52.0%
0.00%
+50.0%
Q4 2021$666,000
+91.9%
48,138
+99.2%
0.00%
-33.3%
Q3 2021$347,000
-15.2%
24,162
-6.5%
0.00%0.0%
Q2 2021$409,000
+74.8%
25,849
+12.2%
0.00%
-66.7%
Q1 2021$234,000
+28.6%
23,040
-5.6%
0.01%
+28.6%
Q4 2020$182,000
+119.3%
24,414
+0.6%
0.01%
+75.0%
Q3 2020$83,000
-21.0%
24,276
+10.1%
0.00%
-20.0%
Q2 2020$105,000
+123.4%
22,048
-6.3%
0.01%
+400.0%
Q1 2020$47,000
-31.9%
23,538
+17.4%
0.00%0.0%
Q4 2019$69,000
+23.2%
20,041
+3.4%
0.00%0.0%
Q3 2019$56,000
-24.3%
19,377
-0.7%
0.00%
-50.0%
Q2 2019$74,000
-42.2%
19,517
+23.8%
0.00%
-33.3%
Q1 2019$128,000
+4.9%
15,768
+3.9%
0.00%0.0%
Q4 2018$122,000
+43.5%
15,172
+2.3%
0.00%
+50.0%
Q2 2018$85,000
+34.9%
14,835
+12.5%
0.00%0.0%
Q1 2018$63,000
-4.5%
13,189
-1.3%
0.00%0.0%
Q4 2017$66,000
+24.5%
13,360
+31.1%
0.00%0.0%
Q3 2017$53,00010,1890.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders